Pet Pharm Biotech Co., Ltd. (TPEX:7762)
56.00
-0.50 (-0.88%)
At close: Sep 10, 2026
| Market Cap | 2.36B -41.3% |
| Revenue (ttm) | 265.54M +67.0% |
| Net Income | 30.03M +56.0% |
| EPS | 0.52 +24.9% |
| Shares Out | 41.69M |
| PE Ratio | 109.68 |
| Forward PE | n/a |
| Dividend | 0.25 (0.51%) |
| Ex-Dividend Date | Jul 20, 2026 |
| Volume | 39,499 |
| Open | 56.50 |
| Previous Close | 56.50 |
| Day's Range | 55.60 - 56.90 |
| 52-Week Range | 44.00 - 89.85 |
| Beta | 0.67 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 13, 2026 |